Otolaryngology Doctors in Bloomington, IL Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Thomas C Ocheltree, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1404 Eastland Dr Ste 209, Bloomington, IL 61701 Phone: 309-662-3277    Fax: 309-663-0845

Christopher D Lansford, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2502 E Empire St Ste A, Bloomington, IL 61704 Phone: 309-589-5900

Willard Noyes, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2502 E Empire St Ste C, Bloomington, IL 61704 Phone: 309-268-3200

Dennis Lee, M.D. Otolaryngology - Pediatric Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 107 N Regency Dr, Bloomington, IL 61701 Phone: 309-662-4411

Robert T Russell, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 1404 Eastland Dr Ste 209, Bloomington, IL 61701 Phone: 309-662-3277    Fax: 309-663-0845

News Archive

Amarantus demonstrates excellent diffusion profile of MANF in the striatum of rat brains

Amarantus BioSciences, Inc., a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that the Company has successfully completed experiments demonstrating that MANF has an excellent diffusion profile in the striatum of rat brains.

Neurotherapeutic video game may help improve cognitive abilities in children with genetic disorders

A UC Davis researcher has created a video game for children who experience cognitive impairments from genetic disorders with the hope that that it will improve their ability to mentally process information about space and time.

Plexxikon announces Phase 1 extension study results of PLX4032 in metastatic colorectal cancer

Plexxikon announced today the results of a Phase 1 extension study in metastatic colorectal cancer that showed clinical activity of PLX4032 as a single agent in this hard-to-treat patient population. PLX4032 is a novel, oral small molecule targeting an oncogenic BRAF mutation found in over 50 percent of melanomas, about 10 percent of colorectal cancers and eight percent of all solid tumors.

Rhei granted marketing approval for MuGard in China

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.

Living environment correlated with reaching centenarian status

When it comes to living to the ripe old age of 100, good genes help but don't tell the full story. Where you live has a significant impact on the likelihood that you will reach centenarian age, suggests a new study conducted by scientists at Washington State University's Elson S. Floyd College of Medicine.

Read more Medical News

› Verified 8 days ago